| 1 | regulation of sequestering of triglyceride (GO:0010889) | 6.50726977 |
| 2 | regulation of somitogenesis (GO:0014807) | 6.02966389 |
| 3 | homocysteine metabolic process (GO:0050667) | 5.82182343 |
| 4 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.66934829 |
| 5 | regulation of plasminogen activation (GO:0010755) | 5.23066043 |
| 6 | viral mRNA export from host cell nucleus (GO:0046784) | 5.17083615 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 5.11117992 |
| 8 | positive regulation of fatty acid oxidation (GO:0046321) | 5.06801167 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.91440195 |
| 10 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.87054951 |
| 11 | regulation of tight junction assembly (GO:2000810) | 4.82727924 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.76357826 |
| 13 | sarcomere organization (GO:0045214) | 4.74769489 |
| 14 | muscle filament sliding (GO:0030049) | 4.60889795 |
| 15 | actin-myosin filament sliding (GO:0033275) | 4.60889795 |
| 16 | desmosome organization (GO:0002934) | 4.60443124 |
| 17 | carnitine shuttle (GO:0006853) | 4.57654857 |
| 18 | negative regulation of DNA biosynthetic process (GO:2000279) | 4.46390843 |
| 19 | cardiac muscle contraction (GO:0060048) | 4.42068002 |
| 20 | white fat cell differentiation (GO:0050872) | 4.41740869 |
| 21 | cell migration involved in heart development (GO:0060973) | 4.38144556 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.36723917 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.24770086 |
| 24 | microtubule nucleation (GO:0007020) | 4.23094841 |
| 25 | cartilage morphogenesis (GO:0060536) | 4.21238150 |
| 26 | response to caffeine (GO:0031000) | 4.16640928 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.11747076 |
| 28 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.11524427 |
| 29 | fatty acid transmembrane transport (GO:1902001) | 4.10269335 |
| 30 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.06875923 |
| 31 | actin-mediated cell contraction (GO:0070252) | 4.04973394 |
| 32 | myofibril assembly (GO:0030239) | 4.02750780 |
| 33 | cardiac muscle hypertrophy (GO:0003300) | 3.98898270 |
| 34 | negative regulation of catenin import into nucleus (GO:0035414) | 3.87982588 |
| 35 | regulation of DNA damage checkpoint (GO:2000001) | 3.87933448 |
| 36 | adenosine metabolic process (GO:0046085) | 3.83781243 |
| 37 | striated muscle hypertrophy (GO:0014897) | 3.83146230 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.82621532 |
| 39 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.80781421 |
| 40 | cardiac myofibril assembly (GO:0055003) | 3.76179673 |
| 41 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.76096032 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.73361814 |
| 43 | cysteine metabolic process (GO:0006534) | 3.72197065 |
| 44 | behavioral response to nicotine (GO:0035095) | 3.71498033 |
| 45 | prostate gland growth (GO:0060736) | 3.70053026 |
| 46 | positive regulation of heart rate (GO:0010460) | 3.69763804 |
| 47 | response to epinephrine (GO:0071871) | 3.68252677 |
| 48 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.67952470 |
| 49 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.67952470 |
| 50 | striated muscle contraction (GO:0006941) | 3.67030920 |
| 51 | response to inactivity (GO:0014854) | 3.64503362 |
| 52 | galactose metabolic process (GO:0006012) | 3.48685012 |
| 53 | purine nucleotide salvage (GO:0032261) | 3.44979830 |
| 54 | regulation of fatty acid oxidation (GO:0046320) | 3.44636384 |
| 55 | regulation of actin filament-based movement (GO:1903115) | 3.44249726 |
| 56 | cardiac muscle cell action potential (GO:0086001) | 3.38055531 |
| 57 | regulation of relaxation of muscle (GO:1901077) | 3.37642307 |
| 58 | muscle hypertrophy (GO:0014896) | 3.36301861 |
| 59 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.35640748 |
| 60 | carnitine transmembrane transport (GO:1902603) | 3.35321024 |
| 61 | otic vesicle formation (GO:0030916) | 3.32229675 |
| 62 | negative regulation of Ras GTPase activity (GO:0034261) | 3.29902843 |
| 63 | regulation of energy homeostasis (GO:2000505) | 3.28666677 |
| 64 | histone H4-K12 acetylation (GO:0043983) | 3.28622305 |
| 65 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.28309046 |
| 66 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.25778426 |
| 67 | regulation of striated muscle contraction (GO:0006942) | 3.19096468 |
| 68 | relaxation of cardiac muscle (GO:0055119) | 3.16048535 |
| 69 | cAMP biosynthetic process (GO:0006171) | 3.15320153 |
| 70 | cardiac muscle adaptation (GO:0014887) | 3.14413797 |
| 71 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.14413797 |
| 72 | muscle hypertrophy in response to stress (GO:0003299) | 3.14413797 |
| 73 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.14362018 |
| 74 | regulation of heart rate (GO:0002027) | 3.13206536 |
| 75 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11908907 |
| 76 | actomyosin structure organization (GO:0031032) | 3.11160944 |
| 77 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.10333799 |
| 78 | positive regulation of histone acetylation (GO:0035066) | 3.09844382 |
| 79 | response to muscle activity (GO:0014850) | 3.09728881 |
| 80 | adrenergic receptor signaling pathway (GO:0071875) | 3.06306122 |
| 81 | regulation of hippo signaling (GO:0035330) | 3.01780571 |
| 82 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.01691681 |
| 83 | carnitine transport (GO:0015879) | 3.01082313 |
| 84 | amino-acid betaine transport (GO:0015838) | 3.01082313 |
| 85 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.98448821 |
| 86 | regulation of membrane repolarization (GO:0060306) | 2.98200450 |
| 87 | cGMP-mediated signaling (GO:0019934) | 2.97657918 |
| 88 | cell communication by electrical coupling (GO:0010644) | 2.97378598 |
| 89 | regulation of cholesterol storage (GO:0010885) | 2.96372905 |
| 90 | cochlea development (GO:0090102) | 2.92265195 |
| 91 | muscle tissue morphogenesis (GO:0060415) | 2.91269648 |
| 92 | striated muscle adaptation (GO:0014888) | 2.89944249 |
| 93 | growth hormone secretion (GO:0030252) | 2.85422351 |
| 94 | lymphangiogenesis (GO:0001946) | 2.83335601 |
| 95 | inner ear receptor cell development (GO:0060119) | 2.83177877 |
| 96 | skeletal muscle adaptation (GO:0043501) | 2.82642804 |
| 97 | galactose catabolic process (GO:0019388) | 2.82574769 |
| 98 | creatine metabolic process (GO:0006600) | 2.82409845 |
| 99 | skeletal muscle contraction (GO:0003009) | 2.81781275 |
| 100 | primary amino compound metabolic process (GO:1901160) | 2.76844799 |
PPP1R26P4 
